Article
High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Chou ST, Jackson T, Vege S, Smith-Whitley K, Friedman DF, Westhoff CM. Blood, 2013. [Citation]
Annotations by Allele
- RHCE*ce667T,697G,712G,733G,744C,787G,800A (ceHAR, ce.22): rhce
- RHCE*ce667T,697G,712G,733G,744C,787G,800A (ceHAR, ce.22): Prevalence
- RHD deletion (RHD*01N.01): Prevalence
- RHD*1136T (DAU0): AbSpecificity (Patient ID 50)
- RHD*1136T (DAU0): AbSpecificity (Patient ID 34)
- RHD*1136T (DAU0): AbSpecificity (Patient ID 214)
- RHD*1136T (DAU0): Prevalence
- RHD*186T,410T,455C,1048C (DIVa): AbSpecificity (Patient ID 14)
- RHD*186T,410T,455C,1048C (DIVa): Prevalence
- RHD*186T,410T,455C,602G,667G,819A (DIIIa): Prevalence
- RHD*186T,410T,455C,667G,1048C (DIVa-like): Prevalence
- RHD*48C (DUC3): Prevalence
- RHD*505C,509G,514T (DFR1, RHD*17.01): Prevalence
- RHD*602G,667G,819A (weak D type 4.0, DAR3.01): AbSpecificity (Patient ID 214)
- RHD*602G,667G,819A (weak D type 4.0, DAR3.01): AbSpecificity (Patient ID 117)
- RHD*602G,667G,819A (weak D type 4.0, DAR3.01): Prevalence
- RHD*667G,697C,1136T (DAU5): AbSpecificity (Patient ID 50)
- RHD*667G,697C,1136T (DAU5): AbSpecificity (Patient ID 104)
- RHD*667G,697C,1136T (DAU5): Prevalence
- RHD*697A,1136T (DAU4): Prevalence
- RHD*697A,1136T (DAU4): AbSpecificity (Patient ID 292)
- RHD*835A,1136T (DAU3): AbSpecificity (Patient ID 104)
- RHD*835A,1136T (DAU3): Prevalence
- RHD*DIIIa-CEVS(4-7)-D (RHD*03N.01): Prevalence
- RHD*Dpsi (RHD*08N.01): Prevalence
- standard RHD (RHD*01): AbSpecificity
- standard RHD (RHD*01): AbSpecificity
- standard RHD (RHD*01): Prevalence
- weak D type 4.2.x (DAR) - partly characterized or subtypes not separated: Prevalence